Exploring the therapeutic potential of MOTS-c in age-related macular degeneration: from cellular responses to patient-derived cybrids.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Cell or laboratory
Published: 2025-02-17
Authors: Mohtashami Z, Schneider K, Azimi R, Atilano S, Chwa M, Kenney MC, Singh MK.
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Polly and Michael Smith; Research to Prevent Blindness; Edith and Roy Carver; Iris and B. Gerald Cantor Foundation; Discovery Eye Foundation; Arnold and Mabel Beckman Initiative for Macular Research; NEI R01
Identifiers: DOI: 10.1007/s13577-025-01188-w · PMID: 39961901
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗